GlassScriptPhysician profile
Terry R Perrine
NPI 1033157391
$1,651.81
in general payments reported to CMS, 2019-2025
18 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $37.37 · 2021: $184 · 2022: $197 · 2023: $378 · 2024: $286 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $303.09 | 2023-2024 | Inspire |
| Otsuka America Pharmaceutical, INC. | $236.96 | 2023-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $196.85 | 2019-2025 | Airsupra |
| Pfizer INC. | $163.28 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.57 | 2024 | Ofev |
| Janssen Pharmaceuticals, INC | $84.67 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $83.91 | 2019 | |
| Phathom Pharmaceuticals, INC. | $80.97 | 2024 | Voquezna |
| Abbvie INC. | $70.55 | 2021-2025 | |
| Boston Scientific Corporation | $62.85 | 2022-2025 | Watchman Flx |
| Astellas Pharma US INC | $52.07 | 2023-2024 | Veozah |
| Novo Nordisk INC | $51.74 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $37.11 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.89 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $21.76 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $20.25 | 2021 | |
| Averitas Pharma INC. | $19.80 | 2023 | Qutenza |
| Dexcom, INC. | $17.49 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Perrine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.